Arnold Bloch Leibler has advised Neuren Pharmaceuticals on its latest capital raising.Neuren Pharmaceuticals (ASX: NEU) has completed a placement of new shares to institutional and sophisticated investors…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
